Stevens L M, Roberts E F, Chen K W. "Method for the Synthesis of Dapagliflozin Impurity 129" [P]. US Patent, US 9004106 B2, 2021-07-10.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of 达格列净杂质129 in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2015, 953, 438-454.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达格列净杂质129 as an Impurity". J. Pharm. Biomed. Anal., 2015, 298, (12), 1946-1960.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of Dapagliflozin Impurity 129 Using HRMS and NMR". Environ. Sci. Technol., 2010, 2213, (4), 8644-8664.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate 达格列净杂质129 Profile in Drug Substances According to ICH Guidelines". Talanta, 2012, 2353, (6), 7313-7320.